Related Experiment Video

Updated: May 26, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed

A Kaas1, C Pfleger, A V Kharagjitsingh

  • 1Department of Paediatrics, Glostrup Hospital and University of Copenhagen, Denmark.

Diabetic Medicine : a Journal of the British Diabetic Association
|December 14, 2011
PubMed

Insights

Serum interleukin 10 (IL-10) levels inversely correlate with age and C-peptide in children with Type 1 diabetes. Increased serum interferon gamma (IFNγ) concentrations are linked to rapid disease progression.

Area of Science:

  • Immunology
  • Endocrinology
  • Pediatrics

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease affecting children.
  • Understanding the role of cytokines like IL-10 and IFNγ in T1D progression is crucial.
  • Genetic factors may influence cytokine production in T1D.

Purpose of the Study:

  • To investigate the relationship between disease progression, age, and serum levels of IL-10 and IFNγ in pediatric T1D patients.
  • To explore the genetic correlates of IL-10 and IFNγ in relation to T1D progression.

Main Methods:

  • Studied 227 newly diagnosed pediatric T1D patients.
  • Classified patients into four progression groups based on C-peptide changes.
  • Genotyped IL-10 and IFNγ gene variants and measured serum cytokine levels at multiple time points.

Main Results:

  • Serum IL-10 decreased with increasing age and was lower with higher C-peptide levels.
  • Serum IFNγ concentrations were higher in patients with rapid disease progression.
  • No association was found between IL-10/IFNγ genotypes and disease progression groups.

Conclusions:

  • Serum IL-10 levels show an inverse relationship with age and C-peptide, suggesting a triangular association.
  • Increased serum IFNγ is associated with faster T1D progression in children.
  • Genetic predisposition appears masked by disease mechanisms influencing cytokine production.
Abstract

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...